Cite

Brain metastases in non-small-cell lung cancer: are tyrosine kinase inhibitors and checkpoint inhibitors now viable options?

MLA

Abdallah, S.Morin-Ben, and A. Wong. “Brain Metastases in Non-Small-Cell Lung Cancer: Are Tyrosine Kinase Inhibitors and Checkpoint Inhibitors Now Viable Options?” Current Oncology (Toronto, Ont.), vol. 25, no. Suppl 1, June 2018, pp. S103–14. EBSCOhost, https://doi.org/10.3747/co.25.3733.



APA

Abdallah, S. M.-B., & Wong, A. (2018). Brain metastases in non-small-cell lung cancer: are tyrosine kinase inhibitors and checkpoint inhibitors now viable options? Current Oncology (Toronto, Ont.), 25(Suppl 1), S103–S114. https://doi.org/10.3747/co.25.3733



Chicago

Abdallah, S Morin-Ben, and A Wong. 2018. “Brain Metastases in Non-Small-Cell Lung Cancer: Are Tyrosine Kinase Inhibitors and Checkpoint Inhibitors Now Viable Options?” Current Oncology (Toronto, Ont.) 25 (Suppl 1): S103–14. doi:10.3747/co.25.3733.